[1] |
El-Serag HB. Hepatocellular carcinoma. N Engl J Med, 2011, 365(12):1118-1127.
|
[2] |
Liu J, Fan D. Hepatitis B in China. Lancet, 2007, 369(9573):1582-1583.
|
[3] |
Shi J, Zhu L, Liu S, et al. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer, 2005, 92(3):607-612.
|
[4] |
Wang JS, Huang T, Su J, et al. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People’s Republic of China. Cancer Epidemiol Biomarkers Prev, 2001, 10(2):143-146.
|
[5] |
Hall AJ, Wild CP. Liver cancer in low and middle income countries. BMJ, 2003, 326(7397):994-995.
|
[6] |
Watts J. Sex, drugs, and HIV/AIDS in China. Lancet, 2008, 371(9607):103-104.
|
[7] |
Lu Y, Robinson M, Zhang FJ. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history and the situation in China. Chin Med J, 2009, 122(1):93-97.
|
[8] |
Qian HZ, Vermund SH, Kaslow RA, et al. Coinfection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS, 2006, 20(10):1429-1435.
|
[9] |
Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology, 2009, 136(1):138-148.
|
[10] |
中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识.中华肝脏病杂志, 2009, 17(6):403-410.
|
[11] |
Wu M. Clinical advances in primary liver cancer in China. Hepatogastroenterology, 2001, 48(37):29-32.
|
[12] |
Shi J, Lai EC, Li N, et al. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. Ann Surg Oncol,2010, 17(8):2073-2080.
|